DE10199025I1 - 8-Chloro-6, 11-dihydro-11-(4-piperidylinen)-5H-benzo 5,6 cyclohepta 1, 2-b pyridin und seine Salze Verfahren zu ihrer Herstellung und diese Verbindungen enhaltende Arzneimittel - Google Patents

8-Chloro-6, 11-dihydro-11-(4-piperidylinen)-5H-benzo 5,6 cyclohepta 1, 2-b pyridin und seine Salze Verfahren zu ihrer Herstellung und diese Verbindungen enhaltende Arzneimittel

Info

Publication number
DE10199025I1
DE10199025I1 DE2001199025 DE10199025C DE10199025I1 DE 10199025 I1 DE10199025 I1 DE 10199025I1 DE 2001199025 DE2001199025 DE 2001199025 DE 10199025 C DE10199025 C DE 10199025C DE 10199025 I1 DE10199025 I1 DE 10199025I1
Authority
DE
Germany
Prior art keywords
cyclohepta
benzo
dihydro
pyridine
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2001199025
Other languages
English (en)
Other versions
DE10199025I2 (de
Inventor
Frank J Villani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10199025(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE10199025I1 publication Critical patent/DE10199025I1/de
Application granted granted Critical
Publication of DE10199025I2 publication Critical patent/DE10199025I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DE2001199025 1984-02-15 1985-02-12 8-Chloro-6, 11-dihydro-11-(4-piperidylinen)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin und seine Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel. Active DE10199025I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58030484A 1984-02-15 1984-02-15

Publications (2)

Publication Number Publication Date
DE10199025I1 true DE10199025I1 (de) 2001-08-02
DE10199025I2 DE10199025I2 (de) 2004-04-01

Family

ID=24320550

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8585101486T Expired DE3573600D1 (en) 1984-02-15 1985-02-12 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzoû5,6¨cyclohepta-û1,2-b¨pyridine and its salts, processes for the production thereof and pharmaceutical compositions containing these compounds
DE2001199025 Active DE10199025I2 (de) 1984-02-15 1985-02-12 8-Chloro-6, 11-dihydro-11-(4-piperidylinen)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin und seine Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8585101486T Expired DE3573600D1 (en) 1984-02-15 1985-02-12 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzoû5,6¨cyclohepta-û1,2-b¨pyridine and its salts, processes for the production thereof and pharmaceutical compositions containing these compounds

Country Status (12)

Country Link
US (1) US4659716A (de)
EP (1) EP0152897B1 (de)
JP (1) JPS61501205A (de)
AT (1) ATE47140T1 (de)
AU (1) AU570306B2 (de)
DE (2) DE3573600D1 (de)
DK (1) DK163059C (de)
FI (1) FI82934C (de)
HU (1) HU194864B (de)
LU (1) LU90738I2 (de)
NL (1) NL300042I2 (de)
WO (1) WO1985003707A1 (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3677842D1 (de) * 1985-05-13 1991-04-11 Schering Corp Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln.
US4804666A (en) * 1985-08-14 1989-02-14 Schering Corporation Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
US4873335A (en) * 1986-03-12 1989-10-10 Schering Corporation 3-phenethyl-2-benzene-amides or aza-derivatives thereof
US5665726A (en) * 1986-10-31 1997-09-09 Schering Corporation Benzo[5,6]cycloheptapyridines, compositions and methods of use
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US5438062A (en) * 1986-10-31 1995-08-01 Schering Corporation Benzo(5,6)cycloheptapyridines, compositions and methods of use
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
ZA893104B (en) * 1988-04-28 1989-12-27 Schering Corp Novel benzopyrido piperidine,piperidylidene and piperazine compounds,compositions,methods of manufacture and methods of use
US4910205A (en) * 1988-05-02 1990-03-20 Schering Corporation Transdermal delivery of loratadine
US4990535A (en) 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
IL98572A (en) * 1990-06-22 1995-07-31 Schering Corp Bite-benzo or benzopyrido compounds Cyclohepta piperidine, piperidylidene and piperazine, preparations and methods of use.
ES2040177B1 (es) * 1992-03-06 1994-05-16 S A Tamarang Procedimiento para la sintesis de la 8-cloro-6, 11-dihidro-11, (1-etoxicarbonil-4-piperidiliden) -5h-benzo (5,6) ciclohepta-(1,2-b) piridina.
EP0635012B1 (de) * 1992-03-27 1996-07-10 Schering Corporation Unverbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
WO1993020080A1 (en) * 1992-03-27 1993-10-14 Schering Corporation Bridged bis-aryl carbinol derivatives, compositions and methods of use
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US5998620A (en) * 1997-03-25 1999-12-07 Schering Corporation Synthesis of intermediates useful in preparing tricyclic compounds
EP0978281B1 (de) * 1997-04-25 2002-07-17 Schering-Plough Kabushiki Kaisha Augentropfen enthaltend ein loratidinmetabolit
US6506767B1 (en) 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
UA62976C2 (en) * 1997-07-02 2004-01-15 Schering Corp Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
US6140337A (en) 1997-12-23 2000-10-31 Schering Corporation Methods for the treatment of mental disorders
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
EP0968715B1 (de) * 1998-06-30 2004-09-01 Pfizer Products Inc. Loratadin zur Verwendung als Antiarrhythmikum
BR9910449A (pt) * 1998-07-10 2001-01-02 Schering Corp Composições orais de 8-cloro-6,11-diidro-11-(4-piperidilideno)-5h-benzo[5,6]c icloepta[1,2-b]piridina
US6423721B1 (en) 1998-09-10 2002-07-23 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6271378B1 (en) 1998-12-18 2001-08-07 Schering Corporation Process for preparing tricyclic compounds having antihistaminic activity
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
JP2003508422A (ja) 1999-09-02 2003-03-04 ノストラム・ファーマスーティカルズ・インコーポレイテッド 放出制御ペレット製剤
EP1214072A2 (de) * 1999-09-21 2002-06-19 Schering Corporation Verwendung von desloratadine zur behandlung von entzündlicher und allergischer zustände
CA2383214A1 (en) * 1999-09-22 2001-03-29 Schering Corporation Treating allergic and inflammatory conditions
US6114346A (en) 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
SK287105B6 (sk) 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
WO2001056571A1 (en) * 2000-02-03 2001-08-09 Schering Corporation Treating allergic and inflammatory conditions
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
ATE460928T1 (de) * 2000-10-23 2010-04-15 Euro Celtique Sa Transdermales system zur verabreichung von loratadin und dessen verwendung
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
HU226998B1 (en) * 2000-11-23 2010-04-28 Richter Gedeon Nyrt Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
WO2002058610A1 (en) * 2001-01-24 2002-08-01 Summanus Pharma, Inc. Alkyl aryl polyether alcohol polymers for improvement of nasal breathing
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
KR20040012747A (ko) * 2001-04-09 2004-02-11 테바 파마슈티컬 인더스트리즈 리미티드 펙소페나딘 염산염의 다형체
US6599913B1 (en) * 2001-06-29 2003-07-29 Schering Corporation Treating allergic and inflammatory conditions
US6720002B2 (en) * 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
ATE400559T1 (de) 2001-08-21 2008-07-15 Schering Corp Verfahren zur herstellung von einem trizyklischen keton zwischenprodukt
WO2003086275A2 (en) * 2002-04-15 2003-10-23 Sun Pharmaceutical Industries Limited Preperation of desloratatine
US20030004179A1 (en) * 2002-05-21 2003-01-02 Affrime Melton B Treating allergic and inflammatory conditions
US20040044038A1 (en) * 2002-06-10 2004-03-04 Barnaba Krochmal Polymorphic form XVI of fexofenadine hydrochloride
US20040001885A1 (en) * 2002-06-27 2004-01-01 Unchalee Kositprapa Rapidly disintegrating antihistamine formulation
GB0216383D0 (en) * 2002-07-13 2002-08-21 Astrazeneca Ab Compounds
PL374799A1 (en) * 2002-08-05 2005-10-31 Sandoz Ag Novel salt and polymorphs of desloratadine hemifumarate
JP2006505590A (ja) * 2002-10-23 2006-02-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒスタミンｈ３受容体調節物質としてのフェニルピペリジンおよびフェニルピロリジン
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
WO2004080461A2 (en) * 2003-03-12 2004-09-23 TEVA Gyógyszergyár Részvénytársaság Stable pharmaceutical compositions of desloratadine
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
AU2003224421A1 (en) * 2003-03-13 2004-09-30 Morepen Laboratories Limited Process for the preparation of loratadine
KR20070007196A (ko) * 2004-04-26 2007-01-12 테바 파마슈티컬 인더스트리즈 리미티드 펙소페나딘 히드로클로라이드의 결정형 및 이의 제조 방법
PL381813A1 (pl) * 2004-07-07 2007-07-23 Egis Gyogyszergyar Nyrt. Nowy pseudopolimorf desloratadiny utworzony z dwutlenkiem węgla
WO2006006184A2 (en) * 2004-07-08 2006-01-19 Morepen Laboratories Limited A process for the manufacturing of loratadine and its intermediates
NL1026634C2 (nl) * 2004-07-12 2006-01-16 Willem Jacob Van Der Burg Psychofarmaceutisch preparaat en werkzame stof daarin.
BRPI0513417A (pt) * 2004-07-16 2008-05-06 Cipla Ltd composição farmacêutica estável, usos de um poliol, e de uma composição, processo para preparar uma composição farmacêutica, e, método para tratar uma condição responsiva à administração de uma anti-histamina
WO2006017505A2 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
US20060148851A1 (en) * 2004-09-28 2006-07-06 Shlomit Wizel Fexofenadine crystal form and processes for its preparation thereof
US20070009558A1 (en) * 2004-12-22 2007-01-11 David Harris Sugar-free storage-stable antihistaminic syrups
US20070004671A1 (en) * 2005-05-20 2007-01-04 Agarwal Sudeep K Stable desloratadine compositions
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US20070060756A1 (en) * 2005-08-11 2007-03-15 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of desloratadine
US20070135472A1 (en) * 2005-12-01 2007-06-14 Glenmark Pharmaceuticals Limited Novel crystalline forms of desloratadine and processes for their preparation
CA2541045A1 (en) * 2006-03-24 2007-09-24 Pharmascience Inc. A descarbonylethoxyloratadine containing pharmaceutical composition
JP5175278B2 (ja) * 2006-06-01 2013-04-03 エムエスディー コンシューマー ケア， インコーポレイテッド 結腸吸収のためのフェニレフリン薬学的製剤および組成物
TWI405567B (zh) * 2006-06-01 2013-08-21 Merck Sharp & Dohme 持續釋放脫羥腎上腺素之醫藥組合物
EP2023957A2 (de) * 2006-06-07 2009-02-18 Morton Grove Pharmaceuticals, Inc. Orale flüssige loratadinformulierungen und verfahren
HU230417B1 (hu) * 2006-10-26 2016-05-30 Egis Gyógyszergyár Zrt Eljárás desloratadine szén-dioxiddal képezett adduktjának előállítására
WO2008107777A2 (en) * 2007-03-06 2008-09-12 Cadila Pharmaceuticals Limited Improved method for the preparation of desloratadine with reduced levels of organic solvents
US20090054338A1 (en) * 2007-08-06 2009-02-26 Aberg A K Gunnar Synergisms between repartitioning and immunomodulating compounds
US20090082385A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched desloratidine
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
US20120101281A1 (en) * 2009-03-26 2012-04-26 Ranbaxy Laboratories Limited Process for the preparation of desloratadine
CN102834406A (zh) 2009-06-16 2012-12-19 默沙东公司 作为糖皮质激素受体激动剂的新的[3.2-c]杂芳基甾体、其组合物和用途
ATE525064T1 (de) 2009-07-01 2011-10-15 Tiefenbacher Alfred E Gmbh & Co Kg Pharmazeutische zusammensetzung mit desloratadin
CA2690490C (en) 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
EP2571485B1 (de) 2010-05-18 2022-02-16 Mahmut Bilgic Antihistamin-brauseformulierungen
DE102010044246B4 (de) 2010-09-02 2015-06-25 Johnson Controls Gmbh Kopfstütze mit zwei Flügelelementen und Verfahren zur Montage eines Flügelelementes
TR201007652A2 (tr) 2010-09-20 2012-04-24 Bi̇lgi̇ç Mahmut Sinerjik etki.
TR201009396A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Desloratadin granüller
US8778971B2 (en) 2012-10-23 2014-07-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in companion animals
US8557846B1 (en) 2012-10-23 2013-10-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in dogs
US20140120121A1 (en) 2012-10-30 2014-05-01 Bridge Pharma, Inc. Medicinal treatment of atopic inflammatory diseases
US20150272941A1 (en) 2012-10-30 2015-10-01 Bridge Pharma, Inc. Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
US9138431B2 (en) 2013-08-06 2015-09-22 Bridge Pharma, Inc. Methods of treatment of histamine H-4 receptor-related pruritus
US10525057B2 (en) 2013-09-24 2020-01-07 Otsuka Pharmaceutical Co., Ltd. Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
CN104961724B (zh) * 2015-06-08 2018-01-30 惠州信立泰药业有限公司 一种获得高纯度地氯雷他定的先进生产工艺
RU2631619C2 (ru) * 2015-08-03 2017-09-25 Общество с ограниченной ответственностью "Трейдсервис" Диспергируемая в воде таблетка дезлоратадина и способ ее изготовления
CN107556237B (zh) * 2017-08-28 2020-11-24 四川大学 一种3-(2-苯乙基)-2-吡啶甲酰胺类化合物的制备方法
CN107400083A (zh) * 2017-08-28 2017-11-28 四川大学 一种3‑[2‑(3‑氯苯基)乙基]‑2‑吡啶甲腈的制备方法
MX2022015335A (es) 2020-12-04 2023-01-11 Laboratorios Silanes S A De C V Combinacion farmaceutica de un corticosteroide y un antihistaminico para el tratamiento y control del componente inflamatorio de procesos alergicos.
CN112898268A (zh) * 2021-04-07 2021-06-04 深圳振强生物技术有限公司 一种地氯雷他定杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (de) * 1963-04-24
US3391143A (en) * 1966-05-16 1968-07-02 Smith Kline French Lab 9-piperidyl and 9-piperidylidene derivatives of acridan
US3717647A (en) * 1971-04-09 1973-02-20 Schering Corp Alpha-nicotinoyl phenylacetonitriles
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines

Also Published As

Publication number Publication date
DE3573600D1 (en) 1989-11-16
DK469485D0 (da) 1985-10-14
WO1985003707A1 (en) 1985-08-29
NL300042I1 (nl) 2001-06-01
JPH0572910B2 (de) 1993-10-13
EP0152897A1 (de) 1985-08-28
FI82934B (fi) 1991-01-31
LU90738I2 (fr) 2001-05-09
HUT38332A (en) 1986-05-28
DK469485A (da) 1985-10-14
EP0152897B1 (de) 1989-10-11
ATE47140T1 (de) 1989-10-15
FI82934C (fi) 1991-05-10
US4659716A (en) 1987-04-21
NL300042I2 (nl) 2001-07-02
FI853675L (fi) 1985-09-25
DK163059C (da) 1992-06-09
JPS61501205A (ja) 1986-06-19
DK163059B (da) 1992-01-13
FI853675A0 (fi) 1985-09-25
HU194864B (en) 1988-03-28
DE10199025I2 (de) 2004-04-01
AU570306B2 (en) 1988-03-10
AU3993885A (en) 1985-09-10

Similar Documents

Publication Publication Date Title
DE10199025I1 (de) 8-Chloro-6, 11-dihydro-11-(4-piperidylinen)-5H-benzo 5,6 cyclohepta 1, 2-b pyridin und seine Salze Verfahren zu ihrer Herstellung und diese Verbindungen enhaltende Arzneimittel
DE3880762D1 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
DE3852554D1 (de) Pyridin-2,4- und 2,5-dicarbonsäureamide, Verfahren zu ihrer Herstellung, Verwendung derselben sowie Arzneimittel auf Basis dieser Verbindungen.
SG44597A1 (en) Benzo[5,6]cycloheptapyridines composition and methods of use
ATE117294T1 (de) Chinolin-derivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
DK0577957T3 (da) 8-Chlor-11-(1-((5-methyl-3-pyridyl)methyl)-4-piperidyliden)-6,11-dihydro-5H-benzo(5,6)cycloheptal(1,2-b)pyridin
HU202520B (en) Process for producing 6,11-dihydro-11-(4-piperidinylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridines and pharmaceutical compositions comprising same
DE3879536T3 (de) Supraleitender keramischer Film und Verfahren zu dessen Herstellung.
NZ501417A (en) Crystalline polymorphs of descarbonylethoxyloratadine (8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta[1,2-b]pyridine) and methods for their use
ATE123022T1 (de) Pyridin-2,4- und 2,5-dicarbonsäure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen.
NO20005485D0 (no) Orale preparater inneholdende 8-klor-6,11-dihydro-11-(4- piperyliden)-5H-benzo-[5,6]syklohepta[1,2-b]pyridin
ATE147388T1 (de) Aminomethyl-substituierte 2,3-dihydropyrano(2,3- b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
HUT52060A (en) Process for producing new, substituted quinoline derivatives and pharmaceutical compositions containing them
NZ231726A (en) 6,11 dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridines and pharmaceutical compositions
IL61176A (en) 6-amino methyl-5,6-dihydro-1,2,4-oxadiazine derivatives,process for their preparation and pharmaceutical compositions containing them
HUT47109A (en) Process for producing 3-(acylaminomethyl)-5,6,7,8-tetrahydro-imidazo-(1,2-a)pyridine derivatives and pharmaceutical compositions comprising these compounds
ZA877919B (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridines and compositions and methods of use
DE3674472D1 (de) Bis-indol-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.